Phreesia, Inc. (NYSE:PHR) Receives $29.33 Average Target Price from Analysts

Shares of Phreesia, Inc. (NYSE:PHR - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the twelve ratings firms that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $29.33.

PHR has been the subject of several analyst reports. Truist Financial lifted their price objective on shares of Phreesia from $31.00 to $34.00 and gave the company a "buy" rating in a research note on Wednesday, December 11th. Royal Bank of Canada reissued a "sector perform" rating and set a $23.00 price objective on shares of Phreesia in a report on Friday, September 27th. Canaccord Genuity Group reissued a "buy" rating and issued a $34.00 price objective on shares of Phreesia in a research note on Thursday, September 5th. DA Davidson reaffirmed a "buy" rating and set a $32.00 target price on shares of Phreesia in a research report on Thursday, September 5th. Finally, JMP Securities reissued a "market outperform" rating and issued a $30.00 price target on shares of Phreesia in a research report on Tuesday, December 10th.

Phreesia Stock Up 5.5 %

NYSE PHR traded up $1.32 on Friday, reaching $25.16. The stock had a trading volume of 749,260 shares, compared to its average volume of 452,361. The company has a current ratio of 1.74, a quick ratio of 1.77 and a debt-to-equity ratio of 0.04. Phreesia has a 1 year low of $17.07 and a 1 year high of $29.16. The business has a 50 day moving average price of $20.81 and a 200 day moving average price of $21.98. The company has a market capitalization of $1.46 billion, a price-to-earnings ratio of -17.12 and a beta of 0.98.

Phreesia (NYSE:PHR - Get Free Report) last announced its quarterly earnings results on Monday, December 9th. The company reported ($0.25) EPS for the quarter, beating the consensus estimate of ($0.29) by $0.04. The business had revenue of $106.80 million during the quarter, compared to analysts' expectations of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The firm's quarterly revenue was up 16.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.58) EPS. On average, analysts forecast that Phreesia will post -1.16 EPS for the current fiscal year.

Insider Buying and Selling

In other Phreesia news, SVP David Linetsky sold 2,011 shares of the firm's stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $21.03, for a total transaction of $42,291.33. Following the completion of the transaction, the senior vice president now owns 201,307 shares in the company, valued at $4,233,486.21. This trade represents a 0.99 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, General Counsel Allison C. Hoffman sold 3,495 shares of Phreesia stock in a transaction that occurred on Wednesday, December 18th. The shares were sold at an average price of $24.88, for a total value of $86,955.60. Following the sale, the general counsel now directly owns 116,296 shares in the company, valued at $2,893,444.48. The trade was a 2.92 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 90,342 shares of company stock valued at $2,041,225 over the last three months. 5.80% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Phreesia

Several hedge funds and other institutional investors have recently modified their holdings of PHR. International Assets Investment Management LLC boosted its stake in Phreesia by 2,179.7% in the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company's stock worth $33,000 after purchasing an additional 1,395 shares in the last quarter. nVerses Capital LLC grew its stake in shares of Phreesia by 76.5% during the second quarter. nVerses Capital LLC now owns 3,000 shares of the company's stock valued at $64,000 after purchasing an additional 1,300 shares during the last quarter. Lombard Odier Asset Management USA Corp acquired a new stake in shares of Phreesia in the second quarter valued at approximately $202,000. Point72 DIFC Ltd acquired a new position in Phreesia during the 2nd quarter worth $209,000. Finally, XTX Topco Ltd bought a new stake in shares of Phreesia during the third quarter worth $247,000. Institutional investors own 92.10% of the company's stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.